journal article·2014-06

Effective delivery of p65 shRNA by optimized Tween 85-polyethyleneimine conjugate for inhibition of tumor growth and lymphatic metastasis

Jisheng Xiao, Xiaopin Duan, Qingshuo Meng, Qi Yin, Zhiwen Zhang, Haijun Yu, Lingli Chen, Wangwen Gu, Yaping Li

Acta Biomaterialia· Volume 10· Issue 6
Publisher page

Abstract

To maximize the interference efficacy of pGPU6/Neo-p65 shRNA-expressing pDNA (p65 shRNA) and subsequently more effectively inhibit tumor growth and lymphatic metastasis through blocking the nuclear factor-kappa B (NF-κB) signaling pathway, seven Tween 85-polyethyleneimine (PEI) conjugates (TnPs, n=2, 3, 4, 5, 6, 7 and 8), which differed in the length of the polymethylene [-(CH2)n-] spacer between Tween 85 and PEI, were synthesized and investigated. The results showed that the transfection efficiency and cytotoxicity both increased with the spacer chain length. Then, TnPs with a [-(CH2)6-] spacer (T6P) were chosen to deliver p65 shRNA to a tumor and subsequently inhibit tumor growth and lymphatic metastasis. The T6P/p65 shRNA complex nanoparticles (T6Ns) could significantly down-regulate p65 expression in breast cancer cells, and consequently inhibit cell invasion and disrupt the tube formation. Most importantly, T6Ns accumulated greatly in tumor tissue, and as a result, significantly inhibited the growth and lymphatic metastasis of breast cancer xenograft. All these results indicated that the transfection efficacies of cationic amphiphiles could be significantly modulated by minor structural variations, and that T6P was promising for the effective delivery of p65 shRNA to knock down the expression of the key metastasis-driving genes and inhibit tumor growth and metastasis.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Immunotherapy and Immune Responses · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. New signals from the invasive front10.1038/nature04872 ↗
2. Lymphangiogenesis and lymphatic metastasis in breast cancer10.1016/j.pathophys.2009.11.003 ↗
3. Intramammary lymph node metastasis predicts poorer survival in breast cancer patients10.1016/j.suronc.2008.12.009 ↗
4. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma10.1002/cncr.20515 ↗
5. Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling10.1038/nature09707 ↗
6. Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma10.1038/nature08462 ↗
7. NF-kappa B functions as a tumour promoter in inflammation-associated cancer10.1038/nature02924 ↗
8. Stabilization of snail by NF-κB is required for inflammation-induced cell migration and invasion10.1016/j.ccr.2009.03.016 ↗
9. NF-kappa B in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF10.1038/nm1519 ↗
10. Nuclear factor-κB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice
11. NF-kappa B genes have a major role in inflammatory breast cancer10.1186/1471-2407-8-41 ↗
12. Prognostic and therapeutic role of nuclear factor-kappa B (NF-kappaB) in breast cancer
13. Role of macrophages in inflammatory lymphangiogenesis: enhanced production of vascular endothelial growth factor C and D through NF-κB activation10.1016/j.bbrc.2008.10.077 ↗
14. Cationic amphiphiles: promising carriers of genetic materials in gene therapy10.1039/b813869a ↗
15. The influence of the structural orientation of amide linkers on the serum compatibility and lung transfection properties of cationic amphiphiles10.1016/j.biomaterials.2011.03.059 ↗
16. Gene transfer efficacies of novel cationic amphiphiles with alanine, β-alanine, and serine headgroups: a structure−activity investigation10.1021/bc0500443 ↗
17. Single additional methylene group in the head-group region imparts high gene transfer efficacy to a transfection-incompetent cationic lipid10.1016/S0014-5793(03)01381-4 ↗
18. Synthesis of novel cationic lipids: effect of structural modification on the efficiency of gene transfer10.1021/jm010918g ↗
19. Nature of linkage between the cationic headgroup and cholesteryl skeleton controls gene transfection efficiency10.1016/S0014-5793(00)01558-1 ↗
20. Synthesis and transfection properties of novel non-toxic monocationic lipids. Variation of lipid anchor, spacer and head group structure10.1016/S0960-894X(00)00099-8 ↗
21. Structure-activity relationship in cationic lipid mediated gene transfection10.2174/0929867033457476 ↗
22. Cationic lipids: molecular structure/transfection activity relationships and interactions with biomembranes
23. Structure-transfection activity relationships with glucocorticoid-polyethyl-enimine conjugate nuclear gene delivery systems10.1016/j.biomaterials.2009.03.042 ↗
24. Low molecular weight polyethylenimine-graft-Tween 85 for effective gene delivery: synthesis and in vitro characteristics10.1021/bc200504v ↗
25. Aliphatic lipid substitution on 2kDa polyethylenimine improves plasmid delivery and transgene expression10.1021/mp900074d ↗
26. Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine10.1021/mp8000815 ↗
27. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking10.1002/smll.201201390 ↗
28. Cationic thermosensitive liposomes: a novel dual targeted heat-triggered drug delivery approach for endothelial and tumor cells10.1021/nl3014154 ↗
29. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles10.1016/j.biomaterials.2010.01.065 ↗
30. New cationic lipid formulations for gene transfer10.1023/A:1016041326636 ↗
31. Gene delivery by lipoplexes and polyplexes10.1016/j.ejps.2010.03.019 ↗
32. In vitro gene transfer efficacies and serum compatibility profiles of novel mono-, di-, and tri-histidinylated cationic transfection lipids: a structure−activity investigation10.1021/bc050194d ↗
33. Design, syntheses and in vitro gene delivery efficacies of novel mono-, di- and trilysinated cationic lipids: a structure−activity investigation10.1021/jm030541+ ↗
34. Cancer invasion and metastasis10.1159/000086626 ↗
35. Cancer invasion and metastasis: changing views10.1002/path.2282 ↗
36. Modification of cysteine residue in p65 subunit of nuclear factor-κB (NF-κB) by picroliv suppresses NF-κB-regulated gene products and potentiates apoptosis10.1158/0008-5472.CAN-08-1902 ↗
37. Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways10.1007/s11033-011-1273-5 ↗
38. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8
39. Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice
40. Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-kappaB inactivation to regulate breast cancer cell invasion10.1002/jcb.23292 ↗
41. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis10.1038/sj.onc.1204535 ↗